Skip to main content

CORRECTION article

Front. Hum. Neurosci., 06 March 2019
Sec. Brain Imaging and Stimulation
Volume 13 - 2019 | https://doi.org/10.3389/fnhum.2019.00081

Corrigendum: The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease

This article is a correction to:

  1. The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease

    1. Read original article
\r\nFernando Maestú,,*Fernando Maestú1,2,3*Pablo Cuesta,Pablo Cuesta1,4Omar HasanOmar Hasan5Alberto Fernandz,Alberto Fernandéz1,6Michael FunkeMichael Funke3Paul E. SchulzPaul E. Schulz5
  • 1Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain
  • 2Department of Experimental Psychology, Universidad Complutense de Madrid, Madrid, Spain
  • 3Magnetic Source Imaging Unit, Department of Pediatrics, McGovern Medical School, University of Texas Health Science Center, Houston, TX, United States
  • 4Electrical Engineering and Bioengineering Lab, Department of Industrial Engineering & IUNE Universidad de La Laguna, Tenerife, Spain
  • 5McGovern Medical School University of Texas Health Science Center, Houston, TX, United States
  • 6Department of Legal Medicine, Psychiatry, and Pathology, Universidad Complutense de Madrid, Madrid, Spain

A Corrigendum on
The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease

by Maestú, F., Cuesta, P., Hasan, O., Fernandéz, A., Funke, M., and Schulz, P. E. (2019). Front. Hum. Neurosci. 13:17. doi: 10.3389/fnhum.2019.00017

In the published article, there was an error in affiliation for Paul Schulz. Instead of affiliation “4”, it should be affiliation “5”, the “McGovern Medical School University of Texas Health Science Center, Houston, TX, United States.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: functional connectivity, mild cognitive impairment, EEG, MEG, healthy aging, Alzheimer's disease

Citation: Maestú F, Cuesta P, Hasan O, Fernandéz A, Funke M and Schulz PE (2019) Corrigendum: The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease. Front. Hum. Neurosci. 13:81. doi: 10.3389/fnhum.2019.00081

Received: 12 February 2019; Accepted: 14 February 2019;
Published: 06 March 2019.

Approved by:

Frontiers In Human Neuroscience Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2019 Maestú, Cuesta, Hasan, Fernandéz, Funke and Schulz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Fernando Maestú, fernando.maestu@uth.tmc.edu; fmaestuu@ucm.es

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.